Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lineage Cell Therapeutics, Inc. (LCTX) vs Yarrow Bioscience, Inc (YARW)

Lineage Cell Therapeutics, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Lineage Cell Therapeutics, Inc. and Yarrow Bioscience, Inc are of similar size ($246.0M and $239.7M). Lineage Cell Therapeutics, Inc. grew revenue faster over the last twelve months: 19.9% against 1.26%. Lineage Cell Therapeutics, Inc. has the higher net margin (−246.6% vs −3,881.5%) and the lower return on invested capital (−186.8% vs 0.00%). Across the 18 metrics below, Lineage Cell Therapeutics, Inc. leads on 10 and Yarrow Bioscience, Inc on 8.

Valuation

Metric LCTX YARW Biotechnology median
P/E n/m n/m 7.88
P/S 19.64 45.00 11.47
P/B 4.30 0.98 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.02 0.74
EV/Sales 15.76 (0.89) 10.73
Earnings yield (13.96%) (80.21%) (28.84%)
Free cash flow yield (9.49%) (78.93%) (23.03%)

Profitability

Metric LCTX YARW Biotechnology median
Gross margin 99.46% 100.00% 65.16%
Operating margin (205.23%) (4,134.44%) 0.00%
Net margin (246.58%) (3,881.54%) 0.00%
Free cash flow margin (186.43%) (3,513.07%) 0.00%
Return on equity (60.35%) (61.40%) (57.72%)
Return on assets (32.75%) (54.77%) (49.22%)
Return on invested capital (186.79%) 0.00% 0.00%

Growth

Metric LCTX YARW Biotechnology median
Revenue growth (TTM) 19.87% 1.26% 5.64%
EPS growth (last fiscal year) (211.11%) 32.26% —
Revenue growth, 5-year CAGR 51.46% (9.35%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LCTX YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.61 15.26 4.73
Net debt to EBITDA 2.64 0.95 0.96

Dividend

Metric LCTX YARW Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LCTX YARW Biotechnology median
Market cap 239.71m 246.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack